Stocks · News reference
NeurAxis shares are trading higher. The company announced new insurance coverage for its IB-Stim PENFS therapy, expanding access to ~26 million health plan members.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Neuraxis, INC (NRXS)
Filed: 2026-10-14 AccNo: 0001493152-26-047034 Size: 201 KB Item 8.01: Other Events
NeurAxis shares are trading higher. The company announced new medical policy coverage from a national health insurer for Percutaneous Electrical Nerve Field Stimulation, spanning multiple states and covering ~18 million members.